All lobbying filings

CAPITOL COUNSEL LLC

CAPITOL COUNSEL LLC filed a Q3 report for ZAI LAB (US) LLC on October 16, 2025, reporting $50,000 in lobbying income.

Lobbying for ZAI LAB (US) LLC · Commercial stage biopharmaceutical company.

All filings by CAPITOL COUNSEL LLC · Everything ZAI LAB (US) LLC has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 16, 2025

Income

$50,000

What the client paid this registrant for the period.

Client based in

Massachusetts

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Financial Institutions/Investments/Securities

Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.

Health Issues

Issues regarding drug manufacturing supply chains, health care and financial services impacting the biotechnology and pharmaceutical industry.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.